Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Perol

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'ImmunotherapieSylvie Negrier, David Perol, Christine Menetrier-Caux, et al.
Bulletin Du Cancer|March 7, 2006
[Prospective study on the quality of care and quality of life in advanced cancer patients treated at home or in hospital: intermediate analysis of the Trapado study]Gisèle Chvetzoff, David Perol, Yves Devaux, et al.
Neuro-Oncology|June 26, 2008
Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trialDidier Frappaz, Matthias Schell, Philippe Thiesse, et al.
Breast Cancer Research and Treatment|December 25, 2010
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006Guillaume Galy, Sana Intidhar Labidi-Galy, David Perol, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Development of a rule based prognostic tool for HER 2 positive breast cancer patientsPaulo J G Lisboa, Terence A Etchells, Ian H Jarman, et al.
Neural Networks : the Official Journal of the International Neural Network Society|February 29, 2008
Time-to-event analysis with artificial neural networks: an integrated analytical and rule-based study for breast cancerPaulo J G Lisboa, Terence A Etchells, Ian H Jarman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2016
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized StudyPascal Pommier, Sylvie Chabaud, Jean-Leon Lagrange, et al.
Cancers|October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological ProcessesFlora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
Oncology|July 8, 2011
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancerThomas Bachelot, Agathe Bajard, Isabelle Ray-Coquard, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'ImmunotherapieSylvie Negrier, David Perol, Christine Menetrier-Caux, et al.
Bulletin Du Cancer|March 7, 2006
[Prospective study on the quality of care and quality of life in advanced cancer patients treated at home or in hospital: intermediate analysis of the Trapado study]Gisèle Chvetzoff, David Perol, Yves Devaux, et al.
Neuro-Oncology|June 26, 2008
Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trialDidier Frappaz, Matthias Schell, Philippe Thiesse, et al.
Breast Cancer Research and Treatment|December 25, 2010
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006Guillaume Galy, Sana Intidhar Labidi-Galy, David Perol, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Development of a rule based prognostic tool for HER 2 positive breast cancer patientsPaulo J G Lisboa, Terence A Etchells, Ian H Jarman, et al.
Neural Networks : the Official Journal of the International Neural Network Society|February 29, 2008
Time-to-event analysis with artificial neural networks: an integrated analytical and rule-based study for breast cancerPaulo J G Lisboa, Terence A Etchells, Ian H Jarman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2016
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized StudyPascal Pommier, Sylvie Chabaud, Jean-Leon Lagrange, et al.
Cancers|October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological ProcessesFlora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
Oncology|July 8, 2011
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancerThomas Bachelot, Agathe Bajard, Isabelle Ray-Coquard, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Pageof 6